Results 101 to 110 of about 884,278 (306)

Natural Test for Random Numbers Generator Based on Exponential Distribution

open access: yesMathematics, 2019
We will prove that when uniformly distributed random numbers are sorted by value, their successive differences are a exponentially distributed random variable Ex(λ).
Ilija Tanackov   +6 more
doaj   +1 more source

Incremental evolution of cellular automata for random number generation

open access: yes, 2003
Cellular automata (CA) have been used in pseudorandom number generation for over a decade. Recent studies show that controllable CA (CCA) can generate better random sequences than conventional one-dimensional (1-d) CA and compete with two-dimensional (2 ...
Zhang, S.   +3 more
core   +1 more source

On Mixed-Integer Random Convex Programs [PDF]

open access: yes, 2012
We consider a class of mixed-integer optimization problems subject to N randomly drawn convex constraints. We provide explicit bounds on the tails of the probability that the optimal solution found under these N constraints will become infeasible for the
D. Lyons   +8 more
core   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Recoverable Random Numbers in an Internet of Things Operating System

open access: yesEntropy, 2017
Over the past decade, several security issues with Linux Random Number Generator (LRNG) on PCs and Androids have emerged. The main problem involves the process of entropy harvesting, particularly at boot time.
Taeill Yoo, Ju-Sung Kang, Yongjin Yeom
doaj   +1 more source

Random Real Numbers [PDF]

open access: yes, 1997
In 1966 Martin-Löf [ML66] has defined random sequences of symbols as a recursion theoretical concept. A sequence of symbols is non-random, iff it is an element of the intersection of a computable sequence of recursively enumerable open sets ...
Weihrauch, Klaus
core  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Strong Laws of Large Numbers for 𝔹-Valued Random Fields

open access: yesDiscrete Dynamics in Nature and Society, 2009
We extend to random fields case, the results of Woyczynski, who proved Brunk's type strong law of large numbers (SLLNs) for 𝔹-valued random vectors under geometric assumptions.
Zbigniew A. Lagodowski
doaj   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

open access: yesMolecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu   +10 more
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

open access: yesMolecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy